These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 33677887
1. [Epithelioid glioblastoma with BRAF V600E mutation: a clinicopathological and molecular study]. Zheng LM, Gong J, Zou Y, Zhang MN, Yu TP, Hou J, Zhou Q, Chen N. Zhonghua Bing Li Xue Za Zhi; 2021 Mar 08; 50(3):229-235. PubMed ID: 33677887 [Abstract] [Full Text] [Related]
2. Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma. Furuta T, Miyoshi H, Komaki S, Arakawa F, Morioka M, Ohshima K, Nakada M, Sugita Y. Neuropathology; 2018 Jun 08; 38(3):218-227. PubMed ID: 29532523 [Abstract] [Full Text] [Related]
3. Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma. Wang J, Liu Z, Cui Y, Liu Y, Fang J, Xu L, He Y, Du J, Su Y, Zou W, Xu Z, Li G. J Neurooncol; 2019 Aug 08; 144(1):137-146. PubMed ID: 31214915 [Abstract] [Full Text] [Related]
4. BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study. Ma C, Feng R, Chen H, Hameed NUF, Aibaidula A, Song Y, Wu J. World Neurosurg; 2018 Dec 08; 120():e1225-e1233. PubMed ID: 30240866 [Abstract] [Full Text] [Related]
5. Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas--Same Entity or First Cousins? Alexandrescu S, Korshunov A, Lai SH, Dabiri S, Patil S, Li R, Shih CS, Bonnin JM, Baker JA, Du E, Scharnhorst DW, Samuel D, Ellison DW, Perry A. Brain Pathol; 2016 Mar 08; 26(2):215-23. PubMed ID: 26238627 [Abstract] [Full Text] [Related]
6. Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations. Murakami C, Yoshida Y, Yamazaki T, Yamazaki A, Nakata S, Hokama Y, Ishiuchi S, Akimoto J, Shishido-Hara Y, Yoshimoto Y, Matsumura N, Nobusawa S, Ikota H, Yokoo H. Brain Tumor Pathol; 2019 Jul 08; 36(3):103-111. PubMed ID: 30972500 [Abstract] [Full Text] [Related]
10. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity. Nakajima N, Nobusawa S, Nakata S, Nakada M, Yamazaki T, Matsumura N, Harada K, Matsuda H, Funata N, Nagai S, Nakamura H, Sasaki A, Akimoto J, Hirato J, Yokoo H. Brain Pathol; 2018 Sep 08; 28(5):663-673. PubMed ID: 29105198 [Abstract] [Full Text] [Related]
11. BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma. Tabouret E, Bequet C, Denicolaï E, Barrié M, Nanni I, Metellus P, Dufour H, Chinot O, Figarella-Branger D. Eur J Surg Oncol; 2015 Dec 08; 41(12):1685-90. PubMed ID: 26454767 [Abstract] [Full Text] [Related]
19. Epithelioid GBMs show a high percentage of BRAF V600E mutation. Kleinschmidt-DeMasters BK, Aisner DL, Birks DK, Foreman NK. Am J Surg Pathol; 2013 May 08; 37(5):685-98. PubMed ID: 23552385 [Abstract] [Full Text] [Related]